Operational information

This data is publicly available. Parent page : ION-5103

Operational data for Canadian Blood Services Stem Cell Registry - ION-5103

Organisation Overview
The information has been reviewed in year :2024
Issuing organisation Number (ION)ION-5103
The Issuing Organisation Number of a organisation, this is globally unique number, as issued by the ICCBBA.
Time zoneAmerica/New_York (GMT-05:00)
The timezone in which this organisation operates.
Business hours8:00 AM to 4:00 PM. Emergency on call number for after hours.
The daily hours in which this organisation operates.
Work scheduleMonday to Friday
The normal work week in which this organisation operates.
Organisation closures
For all organisation closures, please see the WMDA Calendar.
Donor ID exampleGRID: 5103 0001 2345 6789 015
ID to be expected on paperwork, samples, and products.
Preliminary Search
Requires preliminary search request formYes
If yes, form required can be found on the Documents Page.
Extended Typing
Typing options available for requestHR - A, B, C, DRB1, DQB1 or specific bundling; HR - DRB3,4,5, DPB1
Please note special requirements listed
Requires organisation specific typing request formNo
If yes, form required can be found on the Documents Page.
Number of days donor is reserved for a patient after a requestDonor not reserved following completion of Extended Typing
Verification Typing
Maximum blood volume allowed50 mL
Requires organisation specific typing request formNo
If yes, form required can be found on the Documents Page.
IDM testing performed at verificationYes
Number of days donor is reserved for a patient after a request60 days after blood samples have been drawn.
Sibling Typing
Registry is willing to arrange sibling typingsNo
If yes, procedure to apply for sibling typings We do not directly assist with these requests. CBS can facilitate communication from an international registry to a Canadian collection centre.
Workup Request
Product dosage limitPBSC: Rationale must be provided for dosage greater than 5x10^6 cell per patient weight (kg). Marrow: Rationale must be provided for dosage greater than 5x10^8 per patient weight (kg).
Number of donor cells allowed based on recipient weight.
Requires patient to meet certain standards in order to proceed with collectionYes
Organisation may or may not allow donor collections for some patients.
Patient physician must report the following in order to proceed with collectionPatient information including diagnosis, age, gender, weight, transplant history, ABO Rh, CMV status, Patient and Donor HLA typing lab reports, and current disease status.
Must provide additional information to organisation.
Requires organisation specific work up forms No
If yes, form(s) required can be found on the Documents Page.
Workup IDM completed 30 days prior to collectionYes
Donor IDM results must be performed within 30 days of collection date to be valid and allow the collection to proceed.
Medical Health Questionnaire example availableYes
If yes, the example can be found on the Documents Page.
Post-Transplant
Subsequent donation policyEligible Canadian Blood Services Stem Cell Registry donors will only be able to donate a maximum of two hematopoietic stem cells, including any previous unrelated and/or related stem cell donations. Stem Cell Registry donors may make additional therapeutic donations such as leukocytes (DLI), however will be evaluated on a case-by-case basis.
Anonymous contact allowedCanadian Blood Services Stem Cell Registry donors and recipients may exchange anonymous correspondence post-transplant. All correspondence will be screened by the Stem Cell Registry to maintain confidentiality.
Direct contact allowedYes, at the earliest 1 year post-transplant. Direct Contact between a Canadian Blood Services Stem Cell Registry donor and patient is not permitted until at least one year after the most recent donation. Due to the varying regulations of individual transplant centres the request may not be permitted, regardless of Canadian Blood Services Stem Cell Registry policies.
Gift exchange allowedNo
Cord blood contact allowedNo

IDM

IDM TestedMethod Days between test
and sampling/workup
ALT/ASTALT/AST ratio, De-Ritis-Quotient No
ChagasChagas, T. cruzi On requestElecsys ChagasWithin 30 days
CMV IgGCytomegalovirus (CMV) Antibody testing IgG No
CMV IgMCytomegalovirus (CMV) Antibody testing IgM No
CMV TotalCytomegalovirus Total YesCapture-CMV Within 30 days
EBV IgGEpstein-Barr Virus Antibody testing IgG No
EBV IgMEpstein-Barr Virus Antibody testing IgM No
HAV (NAT)Anti-hepatitis A virus nucleic acid testing No
HBV (NAT)Hepatitis B nucleic acid testing Yescobas® MPX – Multiplex HIV, HCV and HBV nucleic acid test for use on the cobas® 6800/8800 SystemsWithin 30 days
HBc AbHepatitis B core antibody testing YesElecsys Anti-HBc II Within 30 days
HBs AgHepatitis B Surface antigen testing YesElecsys HBsAg II Within 30 days
HCV (NAT)Hepatitis C nucleic acid testing Yescobas® MPX – Multiplex HIV, HCV and HBV nucleic acid test for use on the cobas® 6800/8800 SystemsWithin 30 days
HCV AbHepatitis C antibody testing YesElecsys Anti-HCV IIWithin 30 days
HEV (NAT)Hepatitis E Virus nucleic acid testing No
HIV (NAT)Human Immunodeficiency Virus nucleic acid testing Yescobas® MPX – Multiplex HIV, HCV and HBV nucleic acid test for use on the cobas® 6800/8800 SystemsWithin 30 days
HIV-1 AbHuman Immunodeficiency Virus HIV-1 antibody testing YesElecsys HIV Duo Within 30 days
HIV-2 AbHuman Immunodeficiency Virus HIV-2 antibody testing YesElecsys HIV Duo Within 30 days
HIV p24Human Immunodeficiency Virus p24 antigen testing YesElecsys HIV DuoWithin 30 days
HTLV-IHuman T-Lymphotropic Virus type I testing YesElecsys HTLV-I/II Within 30 days
HTLV-IIHuman T-Lymphotropic Virus type II testing YesElecsys HTLV-I/II Within 30 days
MalariaMalaria No
HSVHerpes Simplex Virus No
STSSerological tests for syphilis YesBECKMAN COULTER PK® TP SystemWithin 30 days
STS FTA-ABSSerological test for syphilis No
ToxoplasmosisToxoplasmosis No
VZVVaricella Zoster Virus No
WNV-NATWest Nile Virus nucleic acid testing Yescobas® WNV – Nucleic acid test for use on the cobas® 6800/8800 SystemsWithin 30 days
Other tests performed YesChagas Antibody testing depending upon responses to Health Screening Chagas Risk questions. Confirmatory testing for repeat reactive HBsAg, HCV Ab, HIV-1 Ab, HIV-2 Ab, HTLV-I Ab, HTLV-II Ab, Syphilis and Chagas screening tests.

Regulatory information

The data provided on this page is updated by the organisations.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.

General

The information has been reviewed in year :2024
Organisation name:Canadian Blood Services Stem Cell Registry
Organisation ION:ION-5103
Country:Canada
Year the registry started operations:1988

Products

comment
Do you provide HPC, Marrow? yes
Do you provide HPC, Apheresis? yes
Do you provide HPC, Cord Blood? yes
Do you provide MNC, Apheresis? yes
Do you provide NC, Whole Blood? no

Product quantity

Data valid for year2023
Number of products NationalInternational
HPC, Marrow products: 4 9
HPC, Apheresis: 49 76
HPC, Cord: 0 9

License

Organisation is licensed/accredited by the Competent Authority: yes
Comment:
Name of Competent Authority:Canadian Blood Services Cord Blood Bank is registered with Health Canada
Date of last inspection:Ottawa - 2017/06 - Edmonton - 2020/09
Link to website of Competent Authority:http://www.hc-sc.gc.ca/dhp-mps/compli-conform/info-prod/cell/index-eng.php
Can you provide the Legal documentation from the Competent Authority that your organisation is allowed to operate as a registry ? yes
Is your registry WMDA Certified, WMDA Qualified or WMDA Accredited?WMDA Accredited
The registry is accredited by any other organisation:no
If yes, by which organisation?N/A

Affiliation

The registry works with the following number of affiliated donor centres:N/A
The registry audits its donor centres:N/A
The registry works with the following numer of affiliated collection centres:7
Ther registry audits its collection centres:yes
The registry works with the following number of affiliated Cord Blood Banks:1 (within same organization)
The registry audits its Cord Blood Banks:yes
The registry works with the following number of affiliated transplant centres:11
The registry audits its transplant centres:yes
The registry works with the following number of affiliated IDM Testing Laboratories:2 (within same organization)
The registry audits its IDM Testing Laboratories:yes
The registry works with the following number of affiliated HLA/other DNA markers testing laboratories:2
The registry audits its HLA/other DNA markers testing laboratories:yes
The registry would be able to provide a full list of name/addresses of each affiliated and their licence/accreditation status, on request: yes
The Cord Blood Banks are FACT-NetCord accredited: yes
If yes, the following Cord Blood Bank(s) are accredited:Canadian Blood Services Cord Blood Bank
The registry is able to provide a copy of all the certificates: yes
Affiliated centres comply with WMDA Standards and applicable national regulations: yes
The registry has requirements for affiliated centres in addition to WMDA Standards and applicable national regulations: yes
If yes, what are these requirements?Compliance with MOU

Donor policy

All donors are unpaid volunteers: yes
All donors are informed about donation process and associated risks: yes
Donors sign a valid informed consent to donate in the presence of a medical doctor/health care personnel/registry staff: yes
The registry has systems in place to protect and control access to donor/patient records: yes
The registry maintains donor anonymity: yes
The registry has detailed donor evaluation and exclusion criteria in place: yes
The registry has donor evaluation and exclusion criteria that do meet or exceed the WMDA guidelines: yes


Testing

The physical and medical exam at donor workup is performed by a medical doctor: yes
All donor testing (at workup) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority: yes
HLA typing for patient specific request is performed in an appropriately accredited laboratory: yes
Sterility testing is performed on the adult donor product: yes
Sterility testing is performed on the cord blood product: yes
Screening questionnaire to exclude communicable disease: yes
Screening questionnaire to exclude donors with 'high risk' lifestyles: yes
Donor reliability identified by a medical doctor: yes
Donor clearance to donate is confirmed by a medical doctor, following as a minimum the donor exclusion criteria in Annex 1 of EU Directive 2006/17/EC :

The party providing the cell product must exclude donors when:

  • They are pregnant;
  • They are breastfeeding;
  • There is the potential for transmission of inherited conditions;
  • There is evidence of any other risk factors for transmissible diseases on the basis of a risk assessment, taking into consideration Donor travel and exposure history and local infectious disease prevalence;
  • There is presence on the donor’s body of physical signs implying a risk of transmissible disease(s);
  • There is a history of a disease of unknown aetiology;
  • There is a risk of transmission of diseases caused by prions;
  • There is systemic infection which is not controlled at the time of donation, including bacterial diseases, systemic viral, fungal or parasitic infections, or significant local infection in the tissues and cells to be donated;
  • There is history of chronic, systemic autoimmune disease that could have a detrimental effect on the quality of the Cell Product;
  • There is recent history of vaccination with a live attenuated virus where a risk of transmission is considered to exist;
  • There is ingestion of, or exposure to, a substance (such as cyanide, lead, mercury, gold) that may be transmitted to recipients in a dose that could endanger their health.

Customs regulations

Are there any customs regulations to follow, or customs paperwork required, to import cell products into the organisation country? If yes, please specify:Yes https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/importation-exportation.html
Are there any customs regulations to follow, or customs paperwork required, to export cell products from the organisation country? If yes, please specify:Yes https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/importation-exportation.html
Are there any import regulations to follow, or paperwork required, to import cell products into the organisation country? If yes, please specify:Yes https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/importation-exportation.html
Are there any export regulations to follow, or paperwork required, to export cell products from the organisation country? If yes, please specify:Yes https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/importation-exportation.html

Reporting of Serious Adverse Events

Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in:
- Mandatory National Reporting Schemeno
- Voluntary National Reporting Schemeno
- WMDA SEAR/SPEAR Reporting Scheme yes
The registry will notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product: yes

Quality management

The registry does maintain Standard Operating Procedures for your work: yes
The registry would be willing to provide these to WMDA or another registry upon request: yes
The registry would be willing to provide WMDA or another registry, on request, with copies of any packaging the HPC product will arrive in: yes
Donor records relating to the medical exam and HPC collection process are the following number(s) of year(s) retained:30 years

  • No labels